PROGRAM - Karl-Franzens-Universität Graz · 11.20 - 12.15 Coffee Break, Poster Session 12.45 -...

PROGRAM

Program at a Glance

TimeWednesday,

8 April 2015

Thursday,

9 April 2015

Friday,

10 April 2015

08.00 Registration

08.30 Registration Registration

09.00

09.30

10.00

10.30

11.00

11.30

12.00

12.30

13.00

13.30

14.00

14.30

15.00

15.30

16.00

16.30

17.00

17.30

18.00

18.30

19.00

19.30

Technical ProgramNanomaterials for

Regenerative Medicine

Poster Sessionwith

Wine & Snacks

13.30 - 14.35 Lunch Break

11.05 - 11.40 Coffee Break



12.25 - 13.15Lunch Break


11.20 - 12.15 Coffee Break,

Poster Session

12.45 - 14.00Lunch Break

14.30 End of the Congress

Closing Remarks


Biomedical Applications II

Technical Program

Advances in Nano-

Oncology

Technical ProgramNano- Pharmaceuticals & Drug

Delivery Nanotechnology I

Technical ProgramNanotechnology for Detection,

Diagnostics, Therapeutics & Monitoring II

18.30 Departure to Evening Event


Diagnostics, Therapeutics & Monitoring III


Biomedical Applications I

Panel DiscussionClinical Translation and

Commercialization Aspects


Diagnostics, Therapeutics & Monitoring I

Welcome

18.00 End of Technical Program

Technical Program

Ethics & Societal Issues in

Nanomedicine

Technical ProgramKey Note Session

Technical ProgramBioinspired Nanotechnologies

Poster Awards Ceremony

Technical ProgramNano- Pharmaceuticals & Drug

Delivery Nanotechnology II

Invitation

Nanotechnology enables Personalized

Medicine 8 - 10 April 2015, Graz / Austria

BioNanoMed 2015 provides a forum for clinical physicians, nanoscientists, industry experts as well as educational, governmental and non-governmental institutions for discussing current, emerging and future trends of the converging fields of Nanotechnology, Biotechnology and Medicine.

Exciting lectures and invited talks given by leading international scientists as well as poster presentations offer delegates a good opportunity to discuss pioneering developments and also to initiate cooperation projects.

Topics

NEW FRONTIERS IN MEDICINE & BIOLOGY

- Nanomaterials for Biomedical Applications & Regenerative Medicine

- Nanotechnology for Detection, Diagnostics, Therapeutics & Monitorings

- NanoPharmaceuticals & Drug Delivery Nanotechnology

- Advances in Nano-Oncology

THEMATIC SESSIONS

- Bioinspired Nano-Technologies for Nanomedicine

- Ethics and Societal Issues in Nanomedicine (NanoDiode User Committee on Nanomedicine – co-organized by BioNanoNet GmbH)

SPECIAL SYMPOSIUM

- Clinical Translation and Commercialization Aspects

Important Deadlines

Deadline for poster abstracts: 18 March 2015 End of early registration: 18 February 2015 End of online registration: 3 April 2015

Abstracts for poster presentations are still welcome!

BioNanoMed 2015 - Key / Invited Speaker

Invited – Speaker: Thomas Groth, General of ESAO (European Society for Artificial Organs), Martin Luther University Hall-Wittenberg, (Germany)

Oliver Hayden, Siemens AG, Research and Technology Center, Erlangen (Germany)

Johannes Khinast, Graz University of Technology, Institute for Process and Particle Engineering (Austria)

Iraida Loinaz, CIDETEC-IK4 - Centro de Tecnologías Electroquímicas, New Materials Department, Biomaterials Unit (Spain)

Christian Singer, Medical University Vienna, Head of Senology at Department of Obstetrics and Gynaecology, Vienna (Austria)

Heinz Redl, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, (Austria)

Denis Spitzer, NS3E (Nanomatériaux pour les Systèmes Sous Sollicitations Extrêmes), , French-German Research Institute of Saint-Louis, St Louis (France)

Oommen P. Varghese, Uppsala Univercity, Department of Chemistry- Ångström Laboratory (Sweden)

Andreas Zimmer, University of Graz, Institute of Phrmaceutical Sciences (Austria)

Key – Speaker:

Mauro Ferrari, Alliance for NanoHealth, The Methodist Hospital Research Institute, Ernest Cockrell Jr. Distinguished Endowed Chair, Houston - MedicineWeill Cornell Medical College New York (USA)

Anil K. Patri, FDA -Food and Drug

Administration, National Center for Toxicological Research, Washington D.C. Metro Area (USA)

Quentin Pankhurst, University College London, Centre for Materials Research, Institute of Biomedical Engineering, Faculty of Engineering (United Kingdom)

Jean Pierre Aimé, IECB_CBMN CNRS-University of Bordeaux (France)

Bo Liedberg, Nanyang Technological University, School of Materials Science and Engineering, Center for Biomimetic Sensor Science (Singapore)

João F. Mano, 3B´s Research Group,

Biomaterials, University of Minho, Institute of

Excellence on Tissue Engineering and

Regenerative Medicine, Guimarães (Portugal)

Gerrit Borchard, University of Geneva, Swiss Academy of Pharmaceutical Sciences, European Federation of Pharmaceutical Sciences (Switzerland)

Panel Discussion:

Clinical Translation and Commercialization Aspects Panel Leader: Pinkernell Kai, Miltenyi Biotec GmbH (D)

Program, 8 April 2015

8.00 Registration

9.00 Opening and Welcome

Nanomaterials for Regenerative Medicine

9.20 Nano-Multilayered Polymeric Systems in the Development of new Devices for Tissue

Engineering (Key Note Lecture) João F. Mano, 3B´s Research Group, Biomaterials, University of Minho, Headquarters of the European

Institute of Excellence on Tissue Engineering and Regenerative Medicine, Guimarães (Portugal)

9.55 Human derived Biomaterials and Cells for Tissue Regeneration (Invited Lecture)

Heinz Redl, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for

Tissue Regeneration, Vienna (Austria)

10.20 Biopolymer Nanotechnologies Combined With Stem Cell On Tissue Regeneration

Katherine de Carvalho, Pelé Pequeno Príncipe Institute&Pequeno Príncipe Faculty, Cell Therapy

and Biotechnology in Regenerative Medicine, Curitiba (Brazil)

10.35 Calcium phosphate scaffolds combined with autologous biomaterials in the

treatment of various bone defects: a concept for bone tissue engineering in vivo Dmitry Bulgin, Polyclinic ME-DENT, Department of Molecular Medicine and Cell Technologies, Rovinj

(Croatia)

10.50 TEMPO-pretreated wood nanocellulose for wound dressings

Henriette Rogstad Nordli, Norwegian University of Science and Technology (NTNU), Department of

Cancer Research and Molecular Medicine (IKM), Trondheim (Norway)

11.05 Coffee Break

Nanomaterials for Biomedical Applications I (supported by Erwin Schrödinger Society for Nanosciences)

11.40 Synthetic Peptides and Nanoparticles for Biosensing and Diagnostics (Key Note

Lecture) Bo Liedberg, Nanyang Technological University, School of Materials Science and Engineering, Director of

Center for Biomimetic Sensor Science (Singapore)

12.15 Dendronized magnetic nanoparticles designed for targeting, MRI and hyperthermia Damien Mertz, Institut de Physique et Chimie des Matériaux de Strasbourg IPCMS UMR CNRS-Unistra-

ECPM, Chemistry of inorganic materials, Strasbourg (France)

12.30 Dendritic cell activation mediated by the synergy between amorphous silica

nanoparticles and bacterial factors Regina Tavano, University of Padova, Department of Biomedical Sciences, Padova (Italy)

12.45 Size-dependent anti-coagulant properties of cadmium telluride quantum dots Ciarán Maguire, Trinity College Dublin, Ireland, Clinical Medicine, Institute of Molecular Medicine, Dublin

(Ireland)

13.00 Quantification of nanowire uptake by living cells

Michael Bogdan Margineanu, King Abdullah University of Science and Technology (KAUST), BESE,

Thuwal (Kingdom of Saudi Arabia)

13.15 Insulating Metal Oxide Nanolayers as Advanced Nano-Bio Interfaces for

Impedimetric Nanotoxicological Studies Drago Sticker, AIT Austrian Institute of Technology GmbH, BioSensor Technologies, Vienna (Austria)

13.30 Lunch Break


Nanomaterials for Biomedical Applications II

14.35 Glycosaminoglycans as Building Blocks for Bioactive Nanostructured Surfaces

(Invited Lecture) Thomas Groth, Deputy Secretary General of ESAO (European Society for Artificial Organs), Martin Luther

University Hall-Wittenberg, Biomedical Materials Group, Halle (Germany) 14.55 NanoPORElution – electrochemically etched pores in medical steel as reservoirs

for drug eluting coronary stents Martin Stelzle, NMI Natural and Medical Sciences Institute at the University of Tübingen, BioMEMS and

Sensors, Reutlingen (Germany)

15.10 The strength of heavy atom based nanoparticles to improve medical ion radiation Daniela Edith Salado Leza, Université Paris Sud, Institut des Sciences Moléculaires d'Orsay, Orsay

(France)

15.25 Formation of biolabels by continuous flow encapsulation of fluorescent and

magnetic nanoparticles Jan Niehaus, Center for Applied Nanotechnology (CAN GmbH), Hamburg (Germany)

Bioinspired Nanotechnologies

15.40 DNA Nanodevices & Self Regulated, Self Assembled Nanostructures: A Universal

Language for Life Systems? (Key Note Lecture) Jean Pierre Aimé, IECB_CBMN CNRS-University of Bordeaux (France)

16.15 Continuous engineering of nano-cocrystals by Spray Flash Evaporation (SFE) for

medical issues (Invited Lecture) Denis Spitzer, NS3E (Nanomatériaux pour les Systèmes Sous Sollicitations Extrêmes), , French-German

Research Institute of Saint-Louis, St Louis (France)

16.30 Coffee Break

17.00 PANEL DISCUSSION

- Clinical Translation and Commercialization Aspects Panel Leader: Kai Pinkernell

Head of of Clinical Development, Miltenyi Biotec GmbH, Bergisch Gladbach (Germany)

18.00 Poster Session


Nanotechnology for Detection, Diagnostics, Therapeutics & Monitorings I

9.00 Magnetic Labelling, Targeting and Activation in Cellular Therapies (Key Note

Lecture) Quentin Pankhurst, University College London, Centre for Materials Research, Institute of Biomedical

Engineering, Faculty of Engineering (United Kingdom)

9.35 A titanate-docetaxel nanohybrid monitored by SPECT-CT for the treatment of

prostate cancer Julien Boudon, Université de Bourgogne, Laboratoire Interdisciplinaire Carnot de Bourgogne, Dijon Cedex

(France)

9.50 Different uptake profiles of gold and iron oxide nanoparticles in mouse

macrophages Kuhn Dagmar, University of Fribourg, Adolphe Merkle Institute, Fribourg (Switzerland)

10.05 Development of Biodegradable Polymer Facilitating the Local Treatment of

Radioisotopes Joh Eun-Ha, Korea Atomic Energy Research (KAERI), Department of Research Reactor Utilization, Daejeon

(Republic of Korea)

10.20 A combined nanoparticles-liquid crystal system as detection and separation unit for

a microfluidic point-of-care device for real-time anti-cancer drug monitoring Silke Krol, IRCCS Foundation Institute for Neurology “Carlo Besta”, Nanomed lab, Milan (Italy)

10.35 Coffee Break

Nanotechnology for Detection, Diagnostics, Therapeutics & Monitorings II

11.05 In-vitro diagnostics of non-stable surrogate biomarker (Invited Lecture)

Oliver Hayden, Siemens AG, Research and Technology Center, Erlangen (Germany)

11.25 Identification of Novel Insulin Mimetic Drugs by Quantitative Total Internal

Reflection Fluorescence (TIRF) Microscopy Julian Weghuber, University of Applied Sciences Upper Austria, School of Engineering and Environmental

Sciences, Wels (Austria)

11.40 Multifunctional nanoparticles in medical diagnostics Sofia Dembski, Fraunhofer Institute for Silicate Research ISC, Würzburg (Germany)

11.55 Ultrasensitive Silicon Nanowire for Real-World Gas Sensing: Noninvasive

Diagnosis of Cancer from Breath Volatolome Nisreen Shehada, Technion – Israel Institute of Technology, The Department of Chemical Engineering and

Russell Berrie Nanotechnology Institute, Haifa (Israel)

12.10 Surface modification of silicon nitride based optical waveguide biosensors for

determining kinetic binding parameters of peptide‐ protein interactions Eva Melnik, AIT Austrian Institute of Technology GmbH, Molecular Diagnostics, Vienna ( Austria)

12.25 Lunch Break


Nanotechnology for Detection, Diagnostics, Therapeutics & Monitorings III

13.15 NanoPilot project: A Pilot plant for the production of Polymer based Nano-

pharmaceuticals in Compliance with GMP (Invited Lecture) Iraida Loinaz, CIDETEC-IK4 - Centro de Tecnologías Electroquímicas, New Materials Department,

Biomaterials Unit, San Sebastian (Spain)

13.35 A human Serum albumin based Gene Delivery System for the save Virus free

Application in Gene and Cell Therapy Nadine Wilhelm, Fraunhofer Institute for Biomedical Engineering, Department of Bioprocess Technologies &

Nanotechnology, St. Ingbert (Germany)

13.50 MRI guided cell tracking through off-resonant reconstructions

Clemens Diwoky, Medical University of Graz, Department of Neurology, Graz (Austria)

14.05 L-DOPA-coated manganese oxide nanoparticles as dual MRI contrast agents and

potential drug delivery vehicles Birgitte Hjelmeland McDonagh, Norwegian University of Science and Technlogy, Chemical

Engineering, Trondheim (Norway)

14.20 Developing a Virus Interaction Sensor Platform Christoph Metzner, University of Veterinary Medicine Vienna, Institute of Virology, Vienna (Austria)

14.35 New theranostic applications of dendronised iron oxide nanoparticles

Cristina Blanco-Andujar, CNRS – Université de Strasbourg, Institut de Physique et de Chimie de

Strasbourg (IPCMS) - Department of Inorganic Materials Chemistry (DCMI), Strasbourg (France)

14.50 Coffee Break

Key Note Talks

15.15 The Promise and Pitfalls in Nanomaterial Development for Biomedical

Applications

Anil K. Patri, FDA -Food and Drug Administration, National Center for Toxicological Research,

Washington D.C. Metro Area (USA)

15.50 Nanomedical Ethics: A View from the Trenches

Mauro Ferrari, President of the Alliance for NanoHealth, Houston Methodist Research Institute,

President and CEO Ernest Cockrell Jr. Distinguished Endowed Chair, Houston (USA)


Parallel Session 1) Advances in Nano-Oncology

16.30 Whole Genome Methylation in Breast Cancer (Invited Lacture) Christian Singer, Medical University Vienna, Head of Senology at Department of Obstetrics and

Gynaecology, Vienna (Austria)

16.45 Can nanotechnology help immunotherapy in glioblastoma multiforme? Jochen Belmans, KU Leuven (Belgium), Laboratory of Pediatric Immunology, Department of Microbiology

and Immunology, Leuven (Belgium)

17.00 Core-shell polymer nanoparticles for the combined photo/chemo-therapy of cancers

overexpressing CD44-receptor Fabiana Quaglia, University of Napoli FEDERICO II, Department of Pharmacy, Napoli (Italy)

17.15 Evaluation of the cytotoxic effect of methotrexate and edelfosine lipid nanoparticles

on osteosarcoma primary and metastatic cancer cells Yolanda González Fernández, University of Navarra, Pharmacy and Pharmaceutical Technology,

Pamplona (Spain)

17.30 Gold nanoparticle-bioconjugates as contrast agents for cancer cell recognition and

delivery vehicles of tyrosine kinase inhibitors Sanda Boca-Farcau, Institute

of Oncology “Prof.Dr.Ion Chiricuta”, Cluj-Napoca (Romania)

17.45 Development of metalloprotease-sensitive nanoparticles for doxorubicin release

“on demand”

Valentina Belli, Italian Institute of Technology, Center for Advanced Biomaterials for Health Care @ CRIB, Naples (Italy)

18.00 - End of Session 18.30 - Departure for Evening Discussion

Parallel Session 2) Ethics and Societal Issues in Nanomedicine

(NanoDiode User Committee on Nanomedicine – co-organized by BioNanoNet Forschungsgesellschaft mbH)

(Session Chair: Andreas Falk & Sonja Hartl – BioNanoNet Forschungsgesellschaft mbH)

16:30

What ethical challenges does nanomedicine raise: and how should society address them?

Donald Bruce – Edinethics, Ethics in Science and Technology, Edingbourgh (United Kingdom)

Consumers, Nanotechnology in medicine and responsibilities

Harald Throne-Holst – National Institute for Consumer Research, Oslo (Norway)

NanOpinion – Public opinion on nanotechnologies – project results

Ilse Marschalek – ZSI, Centre for Social Innovation, Vienna (Austria)

17:15 Discussion– Moderation: Sonja Hartl – BioNanoNet Forschungs G mbH What is the reliability of the claims for the nano-products (risk-benefit; advantages, cost, safety, in comparison to conventional approaches)? Do we need a communication approach across the product development (e.g. labelling, standards, etc.); What does Safe-by-design mean to you and how do you explain it to the public? How can we identify societal barriers and drivers for innovation?

17:45 Conclusion

18.00 - End of Session 18.30 - Departure for Evening Discussion


NanoPharmaceuticals & Drug Delivery Nanotechnology I

9.00 Non-biological Complex Drugs (NBCDs): Fundamental Science to Regulatory

Framework (Key Note Lecture) Gerrit Borchard, University of Geneva, President, Swiss Academy of Pharmaceutical Sciences

(SAPhS),Vice-President, European Federation of Pharmaceutical Sciences (EUFEPS), (Switzerland)

9.35 Pharmaceutical Nano-particle Production on an Industrial Scale: Challenges and

Solutions (Invited Lecture) Johannes Khinast, Graz University of Technology, Institute for Process and Particle Engineering (Austria)

9.55 Self-assembled core-shell nanoparticles for drug delivery: structural properties and

kinetic of the release process Imre Dékány, University of Szeged, Supramolecular and Nanostrucured Materials, Szeged (Hungary)

10.10 Interrogating the interaction of metallic nanoparticles with malignant B

Lymphocytes Laura Christine Kickham, Trinity College Dublin, Clinical Medicine, Dublin (Ireland)

10.25 Multicolor Fluorescent Engineered Nanoconstructs with Bimodal Photodynamic

Action Salvatore Sortino, University of Catania, Department of Drug Sciences, Catania (Italy)

10.40 Nanoparticles against Neurodegeneration: Revisit flurbiprofen as an

anti-Alzheimer’s disease drug Julia Stab, Fraunhofer IBMT, Bioprocess Technologies & Nanotechnology, St. Ingbert (Germany)

10.55 Company Presentation

Jörg Uhlig, Malvern Instruments (Germany)

11.10 Poster Award Ceremony - 11.20 Coffee Break

NanoPharmaceuticals & Drug Delivery Nanotechnology II

12.15 Protamine-Oligonucleotide-Nanoparticles: Recent Advances in Drug Delivery and

Drug Targeting (Invited Lacture) Andreas Zimmer, University of Graz, Institute of Phrmaceutical Sciences (Austria)

12.35 Tuning Endosomal Escape: Addressing a Key Bottleneck in Gene Based Therapies

(Invited Lecture) Oommen P. Varghese, Uppsala Univerity, Department of Chemistry- Ångström Laboratory (Sweden)

12.55 An organ-like microfluidic model of the blood–brain barrier for testing novel

methods of nano-particulate drug delivery to the central nervous system Heiko Kiessling, NMI Natural and Medical Sciences Institute at the University of Tübingen (Germany)

13.15 Studying the uptake behavior of Nano-TiO2 into the oral cavity

Eva Roblegg, University of Graz, Pharmaceutical Sciences/ Pharmaceutical Technology, Graz (Austria)

13.30

Screening of Multifunctional Magnetic Iron Oxide Nanoparticles for Theranostic Applications Kieran Crosbie-Staunton, Trinity College Dublin, School of Medicine, Dublin (Ireland)

13.45 Hybrid smart nanoparticles for Theranostics Jose Paulo Sequeira Farinha, University of Lisbon, Instituto Superior Técnico, Licboa (Portugal)

14.00 Bringing the complex issue of the nanoparticle protein corona to simplicity: the

prominent role of plasma Histidine Rich Glycoprotein in silica nanoparticle-cell interaction Emanuele Papini, University of Padova, Biomedical Sciences, Padova (Italy)

14.15 Hitchhiking nanoparticles: Reversible coupling to tumor-specific T cells for targeted

cancer drug delivery Laura Wayteck, Ghent University, Ghent Research Group on Nanomedicines, Gent (Belgium)

14.30 Closing Remarks - 14.40 End of the Congress

BioNanoMed 2015 - Committee

Congress Office

Techkonnex - High-Tech Promotion Auhofstrasse 70/5, 1130 Vienna, Austria, Phone: +43 699 19215844, Email: [email protected]

Organizing Committee Organizing Chair:

Malatschnig Margit, Techkonnex – High-Tech Promotion, Vienna (A)

Scientific Chair:

Falkenhagen Dieter, Danube University Krems (A)

Prassl Ruth, Medical University of Graz (A)

Scientific Advisory Board

Falk Andreas, EURO-NanoTox, BioNanoNet ForschungsGmbH, Graz (A) ++ Ferrari Mauro, President of the Alliance for NanoHealth, The Methodist Hospital Research Institute, Houston (USA)

++ Ellis-Behnke Rutledge, Medical Faculty Mannheim of the Ruprecht-Karls-University

Heidelberg, Director, Nanomedicine Translational Think Tank, MIT - Massachusetts Institute of

Technology, Dept of Brain & Cognitive Sciences (Germany/USA) ++ Gabor Franz, Faculty of Life

Sciences, Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna (A)

++ Groth Thomas, Martin Luther University Hall-Wittenberg, Biomedical Materials Group, Institute

of Pharmacy, Halle (D) ++ Gruner George, University of California Los Angeles, Nano-Biophysics

Group (USA) ++ Hossam Haick, Technion - Israel Institute of Technology, Department of Chemical

Engineering and Russell Berrie Nanotechnology Institute, Haifa (Israel) ++ Hanes Justin, The

Center of Nanomedicine, The Wilmer Eye Institute, John Hopkins School of Medicine, Baltimore

(USA) ++ Helbich Thomas, Medical University Vienna - General Hospital Vienna, Department of

Radiology, Head of Molecular and Gender Imaging, Vienna (Austria) ++ Kirkpatrick C. James, Johannes Gutenberg University, Institute of Pathology, Mainz (D) ++ Kompella Uday B., University

of Colorado Anschutz Medical Campus, Denver (USA) ++ Knoll Wolfgang, Austrian Research

Centers GmbH – ARC, Scientific Managing Director (A) ++ Langer Robert, Koch Institute for

Integrative Cancer Research at MIT-Massachusetts Institute of Technology, Harvard-MIT Department

Health Science and Technology (USA) ++ Lepperdinger Günter, Austrian Academy of Sciences,

Institute for Biomedical Aging Research, Innsbruck (A) ++ Meisel Hans-Jörg, BG-Kliniken

Bergmannstrost, Klinik für Neurochirurgie/Neurozentrum, Halle (D) ++ Moghimi Moein, Centre for

Pharmaceutical Nanotechnology and Nanotoxicology, Department of Pharmacy, University

Copenhagen, Copenhagen (Denmark) ++ Nehrer Stefan, Danube University Krems, Department

Clinical Medicine and Biotechnology (A) ++ Patri Anil K., FDA -Food and Drug Administration,

National Center for Toxicological Research, Washington D.C. Metro Area (USA) ++ Pinkernell Kai, Miltenyi Biotec GmbH (D) ++ Prassl Ruth, Medical University of Graz, Institute of Biophysics (A) ++

Pankhurst Quentin, University College London, Centre for Materials Research, Institute of

Biomedical Engineering, Faculty of Engineering (United Kingdom) ++ Redl Heinz, Ludwig

Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue

Regeneration, VIenna (Austria) ++ Christian F. Singer, Medical University Vienna, Head of

Senology at Department of Obstetrics and Gynaecology, Vienna (Austria) ++ Urban Gerald, IMTEK

- Institute for Mikrosystem Technology, University of Freiburg (D) ++ Jörg Vienken, Fresenius

Medical Care AG & Co. KGaA, Bad Homburg (D) ++ Walpoth Beat, Cardiovascular Research

Service of Cardiovascular Surgery, Geneva University Hospital (CH)

Information

Congress Language English

Erwin Schrödinger Society Poster Awards Erwin Schrödinger Society Awards 2014 are granted to the best three poster contributions (€ 300,- for the first, € 200,- for the second and € 100,- for the third place). Awarded by Erwin Schrödinger Society for Nanosciences.

Participation for Students

The student fee applies to predoctoral full-time students only (please send a letter with signature and stamp from the University to [email protected]).

Exhibition & Sponsoring

BioNanoMed 2015 serves as an excellent platform to present your company/ institution, to promote your product portfolio and to establish direct links to a broad audience of experts By becoming an exhibitor or sponsor you will make a great contribution to support the BioNanoMed 2015 congress. Pleae turn to our website!

Congress Fees

Academic Delegate - Early registration:€ 400,- (valid until 18 February 2015)

Academic late Delegate: € 450,- (On-Site € 495,-)

Industry Delegate - Early registration: € 455,- (valid until 18 February 2014)

Industry late Delegate: € 500,- (On-Site € 550,-)

Students - Early registration:€ 295,- (valid until 18 February 2014)

Students late registration: € 335,- (On-Site € 375,-)

The congress fee includes admission to scientific programme, poster sessions and exhibition, congress documentation and refreshments during the coffee breaks.

BioNanoMed 2015

8 – 10 April 2015, Graz / Austria Medical University of Graz (Hörsaalzentrum)

Auenbruggerlatz 15, 8036 Graz

Medical University of Graz

www.medunigraz.at

BioNanoNet Forschungs GmbH

www.bionanonet.at

Danube University Krems

www.donau-uni.ac.at

Information I www.bionanomed.at E [email protected]

This congress is organized by

Techkonnex – High-Tech Promotion Auhofstrasse 70/5, 1130 Vienna/Austria

www.techkonnex.at

in cooperation with

This congress is supported by

Media Partner

http://www.bionanomed.at/

mailto:[email protected]

http://www.techkonnex.at/

PROGRAM - Karl-Franzens-Universität Graz · 11.20 - 12.15 Coffee Break, Poster Session 12.45 -...

Documents

Transcript of PROGRAM - Karl-Franzens-Universität Graz · 11.20 - 12.15 Coffee Break, Poster Session 12.45 -...